579525-46-5

Basic information

• Product Name: 2-(Dimethylamino)pyridine-5-boronic acid hydrate
• Synonyms: 2-(DIMETHYLAMINO)PYRIDINE-5-BORONIC ACID HYDRATE;6-(DIMETHYLAMINO)PYRIDINE-3-BORONIC ACID HYDRATE;Boronic acid, [6-(dimethylamino)-3-pyridinyl]- (9CI);2-(Dimethylamino)pyridine-5-boronicacid;2-(N,N-Dimethylamino)pyridine-5-boronic acid hydrate;5-Borono-2-(dimethylamino)pyridine hydrate;2-DiMethylaMino-5-pyridineboronic acid
• CAS NO: 579525-46-5
• Molecular Formula: C₇H₁₁BN₂O₂
• Molecular Weight: 165.99
• Product Categories: AMINETERTIARY;Amino;Organoborons;Pyridine;Boronate Ester;Boronic Acid;Potassium Trifluoroborate
• Mol File: 579525-46-5.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 352.3ºC at 760 mmHg
• Flash Point: 166.8ºC
• Appearance: /
• Density: 1.19g/cm3
• Vapor Pressure: 1.44E-05mmHg at 25°C
• Refractive Index: 1.548
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• PKA: 4.21±0.10(Predicted)
• CAS DataBase Reference: 2-(Dimethylamino)pyridine-5-boronic acid hydrate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(Dimethylamino)pyridine-5-boronic acid hydrate(579525-46-5)
• EPA Substance Registry System: 2-(Dimethylamino)pyridine-5-boronic acid hydrate(579525-46-5)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22
• HazardClass: IRRITANT
• Hazardous Substances Data: 579525-46-5(Hazardous Substances Data)

Usage

Uses

2-(Dimethylamino)pyridine-5-boronic acid, hydrade

InChI:InChI=1/C7H11BN2O2/c1-10(2)7-4-3-6(5-9-7)8(11)12/h3-5,11-12H,1-2H3

Upstream product

• 26163-07-5 5-bromo-2-dimethylaminopyridine 
• 5419-55-6 Triisopropyl borate 
• 624-28-2 2,5-dibromopyridine 
• 766-11-0 5-bromo-2-fluoropyridine 
• 73183-34-3 bis(pinacol)diborane 

Downstream Products

• 1039733-87-3 N-{4-[({2-(dimethylamino)-6-[5-(dimethylamino)pyridin-2-yl]quinazolin-4-yl}amino)methyl]phenyl}-4-fluorobenzamide 
• 1311412-27-7 C₂₄H₃₁N₃O₄ 
• 1311412-23-3 C₂₄H₃₃N₃O₅ 
• 1311411-86-5 C₄₀H₄₇FN₄O₆ 
• 1311411-91-2 C₄₆H₆₀F₂N₄O₆Si 
• 1350659-22-1 [Fe(C₅H₅)(C₅H₃C₄H₂N₂C₅H₃N(N(CH₃)2))PdCl(P(C₆H₅)3)] 
• 1380106-69-3 3-[2-chloro-4-(6-dimethylamino-pyridin-3-yl)-phenyl]-N-hydroxy-acrylamide hydrochloride 
• 1416976-16-3 C₄₀H₄₅ClF₂N₄O₆ 
• 1416976-22-1 C₃₈H₅₁FN₄O₅ 
• 1435105-33-1 C₂₃H₂₅N₃O₄S₂ 
• 1416914-85-6 1-(4-(6-(dimethylamino)pyridin-3-yl)benzyl)-3-methoxypyridin-2-one 
• 1448015-78-8 cyclopropanecarboxylic acid {4-[4-(6-dimethylaminopyridin-3-yl)phenyl]thiazol-2-yl}amide 
• 1362144-55-5 C₂₁H₂₀N₆O₃S 
• 1460300-37-1 C₁₄H₁₇N₃O₂S 

Relevant articles and documents

Facile Palladium-Catalyzed Synthesis of 3-Arylpyrazolo-[1,5-a]pyrimidines

An efficient palladium-catalyzed synthesis of 3-arylpyrazolo[1,5-a] pyrimidines has been investigated. The key step in the synthesis is a Suzuki biaryl coupling of 3-bromo-2,5-dimethyl-7-aminopyrazolo[1,5-a]pyrimidines with arylboronic acids to provide 3-

ANTI-MALIGNANT TUMOR AGENT COMPOSITION

To provide a satisfactory anticancer agent composition suppressing the growth of cancer (malignant tumor) reliably and hardly causing side effects, the present invention is directed to an anticancer agent composition including the following agents as active ingredient; a LAT1 inhibitor, and one or more agents selected from the group consisting of an alkylating agent, a platinum-based antineoplastic agent, an anti-metabolite, a topoisomerase inhibitor, an anti-microtubule polymerizing agent, a hormonal agent, an anti-microtubule depolymerizing agent, an anticancer antibiotic, and a molecular targeted agent.

SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS

Provided are certain pyridopyrazine compounds, pharmaceutical compositions thereof and methods of use therefor.